Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 4, 2012, Pages 858-864

  Fornasa, Francesca ^a   Nesoti, Maria Vittoria ^b   Bovo, Chiara ^b   Bonavina, Maria Giuseppina ^b  

^a San Bonifacio Hospital   (Italy)

^b Local Health Trust General Management   (Italy)

Author keywords

apparent diffusion coefficient; breast cancer; diffusion weighted magnetic resonance imaging; lymph nodes; staging

Indexed keywords

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; BREAST EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866349768     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23706     Document Type: Review

References (40)

1. Silverstein MJ, Skinner KA, Lomis TJ,. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001; 25: 767-772. (Pubitemid 32531925)
2. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 2006; 98: 599-609. (Pubitemid 43904843)
3. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001; 42: 1198-1215. (Pubitemid 32717839)
4. Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A,. Metastases in small lymph nodes from colon cancer. Arch Surg 1987; 122: 1253-1256. (Pubitemid 18021277)
5. Ahn JH, Son EJ, Kim JA, et al. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer. Acta Radiol 2010; 51: 859-865.
6. Chae BJ, Bae JS, Kang BJ, Kim SH, Jung SS, Song BJ,. Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer. Jpn J Clin Oncol 2009; 39: 284-289.
7. Alvarez S, Añorbe E, Alcorta P, Lõpez F, Alonso I, Cortés J,. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol 2006; 186: 1342-1348. (Pubitemid 46112571)
8. Mills P, Sever A, Weeks J, Fish D, Jones S, Jones P,. Axillary ultrasound assessment in primary breast cancer: an audit of 653 cases. Breast J 2010; 16: 460-463.
9. Heusner TA, Kuemmel S, Hahn S, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging 2009; 36: 1543-1550.
10. Shien T, Akashi-Tanaka S, Yoshida M, et al. Evaluation of axillary status in patients with breast cancer using thin-section CT. Int J Clin Oncol 2008; 13: 314-319.
11. Cooper K, Meng Y, Harnan S, et al. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation. Health Technol Assess 2011; 15: 1-134.
12. Harada T, Tanigawa N, Matsuki M, Nohara T, Narabayashi I,. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur J Radiol 2007; 63: 401-407. (Pubitemid 47321038)
13. Harisinghani MG, Dixon WT, Saksena MA, et al. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 2004; 24: 867-878. (Pubitemid 38703252)
14. Kim JK, Kim KA, Park BW, Kim N, Cho KS,. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 2008; 28: 714-719.
15. Bammer R, Liu C, Po J, Moseley ME,. Diffusion-weighted magnetic resonance imaging. In:, Edelman S, Hesselink JR, Zlatkin MB, Crues JV, editors. Clinical magnetic resonance imaging, 3rd ed. Philadelphia: Saunders; 2008. p 288-319.
16. Fornasa F, Pinali L, Gasparini A, Toniolli E, Montemezzi S,. Diffusion-weighted magnetic resonance imaging in focal breast lesions: analysis of 78 cases with pathological correlation. Radiol Med 2011; 116: 264-275.
17. McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA,. Diffusion-weighted MRI in cervical cancer. Eur Radiol 2008; 18: 1058-1064.
18. Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A,. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006; 16: 1468-1477. (Pubitemid 43871818)
19. Akduman EI, Momtahen AJ, Balci NC, Mahajann N, Havlioglu N, Wolverson MK,. Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging. Acad Radiol 2008; 15: 641-646. (Pubitemid 351509765)
20. Beer AJ, Eiber M, Souvatzoglou M, et al. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol Imaging Biol 2010; 13: 352-361.
21. Chen YB, Liao J, Xie R, Chen GL, Chen G,. Discrimination of metastatic from hyperplastic pelvic lymph nodes in patients with cervical cancer by diffusion-weighted magnetic resonance imaging. Abdom Imaging 2011; 36: 102-109.
22. De Bondt RB, Hoeberigs MC, Nelemans PJ, et al. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 2009; 51: 183-192.
23. Eiber M, Beer AJ, Holzapfel K, et al. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 2010; 45: 15-23.
24. Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J,. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009; 72: 381-387.
25. King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphoadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 2007; 245: 806-813. (Pubitemid 350127351)
26. Mizukami Y, Ueda S, Mizumoto A, et al. Diffusion-weighted Magnetic Resonance Imaging for detecting lymph node metastasis of rectal cancer. World J Surg 2011; 35: 895-899.
27. Park SO, Kim JK, Kim KA, et al. Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer. J Magn Reson Imaging 2009; 29: 383-390.
28. Perrone A, Guerrisi P, Izzo L, et al. Diffusion-weighted MRI in cervical lymph nodes: differentiation between benign and malignant lesions. Eur J Radiol 2011; 77: 281-286.
29. Sakurada A, Takahara T, Kwee TC, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 2009; 19: 1461-1469.
30. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003; 24: 1627-1634. (Pubitemid 37151732)
31. Sumi M, Van Cauteren M, Nakamura T,. MR microimaging of benign and malignant nodes in the neck. AJR Am J Roentgenol 2006; 186: 749-757. (Pubitemid 46100259)
32. Vandecaveye V, De Keyzer F, Vanderpoorten V, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009; 251: 134-146.
33. Yasui O, Sato M, Kamada A,. Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer. Tohoku J Exp Med 2009; 218: 177-183.
34. Lin G, Ho KC, Wang JJ, et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 2008; 28: 128-135. (Pubitemid 351956475)
35. Nakai G, Matsuki M, Inada Y, et al. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 2008; 32: 764-768.
36. Pauls S, Schmidt SA, Juchems MS, et al. Diffusion-weighted MR imaging in comparison to integrated [(18)F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol 2012; 81: 178-182.
37. Roy C, Bierry G, Matau A, Bazille G, Pasquali R,. Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T. Eur Radiol 2010; 20: 1803-1811.
38. Kwee TC, Takahara T, Luijten PR, Nievelstein RA,. ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 2010; 75: 215-220.
39. Heusner TA, Kuemmel S, Koeninger A, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 2010; 37: 1077-1086.
40. Hoehn-Berlage M, Eis M, Schmitz B,. Regional and directional anisotropy of apparent diffusion coefficient in rat brain. NMR Biomed 1999; 12: 45-50. (Pubitemid 29135409)